TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas

NCT01851369 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

93

Enrollment

NIH

Sponsor class

Conditions

Lymphomas
Solid Tumors
NSCLC
Metastatic Colon Carcinoma
Granulosa Cell Ovarian Cancer

Interventions

DRUG: TRC102
DIAGNOSTIC_TEST: CT scan
OTHER: Lomotil
OTHER: Prochlorperazine
OTHER: Metoclopramide
OTHER: 5-HT3 antagonist
OTHER: Aprepitant
PROCEDURE: Biopsy

Sponsor

National Cancer Institute (NCI)